Last week in Texas, Senator Kevin Eltife (R-Tyler) filed SB 339 and Representative Stephanie Klick (R-Fort Worth) filed HB 892, both relating to the medical use of low-THC cannabis. RAMP has the utmost respect for Representative Klick’s and Senator Eltife’s advocacy for patients with epilepsy to have access to safe medical marijuana when no other treatment options provide relief. However, it is clear from experience in other states that CBD-only legislation has failed to generate the high-CBD strains that epileptic patients desperately need. The Texas Compassionate Use Act limits the market to such a degree that people will be unlikely to invest money and time into the extremely difficult practice of medical marijuana cultivation. Colorado, a state with whole plant access, has lead the nation in high-CBD marijuana strains while also helping patients who benefit from THC – such as those with cancer, muscular sclerosis, and PTSD. RAMP advocates a bill that allows the entire plant to be accessed as medicine for qualifying conditions including cancer, glaucoma, HIV/AIDS, Crohn’s disease, ulcerative colitis, Alzheimer’s, PTSD, and conditions causing seizures, severe pain, severe nausea, and muscle spasms.